journal article Jul 01, 1987

Opioid modulation of the discriminative stimulus produced by pentylenetetrazol

View at Publisher Save 10.1007/bf00210836
Topics

No keywords indexed for this article. Browse by subject →

References
59
[1]
Ayhan IH, Randrup A (1973) Behavioral and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines. Psychopharmacologia 29:317?328 10.1007/bf00429279
[2]
Beecher HK (1957) The measurement of pain. Pharmacol Rev 9:59?209
[3]
Bonica JJ (1979) Important clinical aspects of acute and chronic pain. In: Beers RF Jr, Bassett EG (eds) Mechanisms of pain and analgesic compounds. Raven, New York, pp 15?29
[4]
Chait LD, Wenger GR, McMillan DE (1981) Effects of phencyclidine and ketamine on punished and unpunished responding by pigeons. Pharmac Biochem Behav 15:145?148 10.1016/0091-3057(81)90354-3
[5]
Colpaert FC (1978) Some properties of drugs as physiological signals: the FR procedure and signal detection theory. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier/North Holland, Amsterdam, pp 217?242
[6]
Colpaert FC, Janssen PAJ (1984) Agonist and antagonist effects of prototypic opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther 230:193?199
[7]
Colpaert FC, Lal H, Niemegeers CJE, Janssen PAJ (1975) Investigations on drug produced and subjectively experienced discriminative stimuli. 1. The fentanyl cue, a tool to investigate subjectively experienced narcotic drug actions. Life Sci 16:705?716 10.1016/0024-3205(75)90347-1
[8]
Colpaert FC, Niemegeers CJE, Janssen PAJ (1976) Fentanyl and apomorphine: asymmetrical generalization of discriminative stimulus properties. Neuropharmacology 15:541?545 10.1016/0028-3908(76)90105-2
[9]
Colpaert FC, Niemegeers CJE, Janssen PAJ (1980) Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination. J Pharmacol Exp Ther 212:474?480
[10]
Cook L, Davidson AB (1973) Effect of behaviourally active drugs in a conflict-punishment procedure in rats. In: Garattini S, Mussini, Randall (eds) The benzodiazepines. Raven, New York, pp 355?366
[11]
Cools AR, Janssen HJ, Broekkamp CLE (1974) The differential role of the caudate nucleus and the linear raphe in the initiation and the maintenance of morphine-induced behavior in cats. Arch Int Pharmacodyn 210:163?174
[12]
De Rossett SE, Holtzman SG (1984) Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey. J Pharmacol Exp Ther 228:669?675
[13]
Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a beta carboline ligand for benzodiazepine receptors. Lancet ii:98?99 10.1016/s0140-6736(83)90076-4
[14]
Emmett-Oglesby MW, Spencer DG Jr, Arnoult DE (1982) A TRS-80 based system for the control of behavioral experiments. Pharmacol Biochem Behav 17:583?587 10.1016/0091-3057(82)90322-7
[15]
Emmett-Oglesby MW, Spencer DG Jr, Lewis MW, Elmesallamy F, Lal H (1983) Anxiogenic aspects of diazepam withdrawal can be detected in animals. Eur J Pharmacol 92:127?130 10.1016/0014-2999(83)90117-6
[16]
Emmett-Oglesby MW, Harris CM, Lane JD, Lal H (1984) Withdrawal from morphine generalizes to a pentylenetetrazol stimulus. Neuropeptides 5:37?40 10.1016/0143-4179(84)90021-0
[17]
Gherezghiger T, Lal H (1982) RO 15?1788 selectively reverses antagonism of pentylenetetrazol-induced discriminative stimuli by benzodiazepines but not by barbiturates. Life Sci 31:2955?2960 10.1016/0024-3205(82)90061-3
[18]
Gilbert PE, Martin WR (1976) The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J Pharmacol Exp Ther 198:66?82
[19]
Gmerek DE, Woods JH (1985) Effects of ?-funaltrexamine in normal and morphine-dependent rhesus monkeys: observation studies. J Pharmacol Exp Ther 235:296?301
[20]
Hein DW, Young AM, Herling S, Woods JH (1981) Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. J Pharmacol Exp Ther 218:7?15
[21]
Herz A (1984) Multiple opioid receptors. In: Delitala G (eds) Opioid modulation of endocrine function. Raven, New York, pp 11?19
[22]
Holtzman SG (1985) Drug discrimination studies. Drug Alcohol Depend 14:263?282 10.1016/0376-8716(85)90061-4
[23]
Jasinski DR (1977) Assessment of the abuse potentiality of morphinelike drugs (methods used in man). In: Martin WR (ed) Handbook of experimental pharmacology, drug addiction I. Springer, New York Berlin Heidelberg, pp 197?258 10.1007/978-3-642-66612-4_4
[24]
Katz JL, Woods JH, Winger GD, Jacobson AE (1982) Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys. Life Sci 31:2375?2378 10.1016/0024-3205(82)90160-6
[25]
Kelleher RT, Morse WH (1964) Escape behavior and punished behavior. Fed Proc 23:818?835
[26]
Kuschinsky K, Hornykiewicz O (1972) Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Eur J Pharmacol 19:119?122 10.1016/0014-2999(72)90086-6
[27]
Lahti RA, Mickelson MM, McCall JM, Von Voigtlander PFV (1985) 3[H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol 109:281?284 10.1016/0014-2999(85)90431-5
[28]
Lal H, Emmett-Oglesby MW (1983) Behavioral analoues of anxiety. Neuropharmacology 22:1423?1441 10.1016/0028-3908(83)90111-9
[29]
Lal H, Shearman GT (1980) Interoceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety. Annu Rep Med Chem 15:51?58
[30]
Lal H, Emmett-Oglesby MW, Spencer DG Jr, Elmesallamy F (1984) Subjective signs of precipitated withdrawal from triazolam. Fed Proc 43:931
[31]
Leaf RC, Muller SA (1965) Effects of shock intensity, deprivation and morphine in a simple approach-avoidance conflict situation. Psychol Rep 17:819?823 10.2466/pr0.1965.17.3.819
[32]
Magnan J, Paterson SJ, Tyvani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties Nauyn-Schmiedeberg's Arch Pharmacol 319:197?205 10.1007/bf00495865
[33]
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517?532
[34]
Martin WR, Sloan JW (1977) Neuropharmacology and neurochemistry of subjective effects, analgesia, tolerance, and dependence produced by narcotic analgesics. In: Martin WR (ed) Handbook of experimental pharmacology, drug addiction I. Springer, New York Berlin Heidelberg, pp 43?158 10.1007/978-3-642-66612-4_2
[35]
McMillan DE (1973) Drugs and punished responding. I. Rate-dependent effects under multiple schedules. J Exp Anal Behav 19:133?145 10.1901/jeab.1973.19-133
[36]
McMillan DE, Leander JD (1975) Drugs and punished responding. V. Effects of drugs on responding suppressed by response-dependent and response-independent electric shock. Arch Int Pharmacodyn 213:22?27
[37]
Merz H, Stockhaus K, Wick H (1975) Stereoisomeric 5,9-dimethyl-2?-hydroxy-2-tetrahydrofurfuryl-6,7-benzomorp compounds with differentiated opioid action profiles. J Med Chem 22:1475?1483 10.1021/jm00198a009
[38]
Millan MJ, Duka T (1981) Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry 17:123?141 10.1159/000402410
[39]
Mirin SM, Meyer RE, McNamee HB (1976) Psychopathology and mood during heroin use. Arch Gen Psychiatry 33:1503?1508 10.1001/archpsyc.1976.01770120107011
[40]
Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274?280 10.1007/bf00432213
[41]
Paule MG, Wenger GR (1986) Morphine discrimination in the pigeon using a color tracking procedure. Pharmacol Biochem Behav 24:597?604 10.1016/0091-3057(86)90564-2
[42]
Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 133:774?776 10.1126/science.3016896
[43]
Römer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK, Akkerman AM (1980) Bremazocine: a potent long-acting kappa-agonist. Life Sci 27:971?979 10.1016/0024-3205(80)90107-1
[44]
Sannerud CA, Young AM (1986) Modification of morphine tolerance by behavioral variables. J Pharmacol Exp Ther 237:75?81
[45]
Shannon HE (1981) Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. J Pharmacol Exp Ther 216:543?551
[46]
Shannon HE (1983) Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat. J Pharmacol Exp Ther 225:144?152
[47]
Shearman GT, Herz A (1982a) Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists. Psychopharmacology 78:63?66 10.1007/bf00470590
[48]
Shearman GT, Herz A (1982b) Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors. J Pharmacol Exp Ther 221:735?739
[49]
Shearman GT, Lal H (1979) Discriminative stimulus properties of pentylenetetrazol and bemegride: some generalization and antagonism tests. Psychopharmacology 64:315?319 10.1007/bf00427516
[50]
Shearman GT, Lal H (1981) Discriminative stimulus properties of cocaine related to an anxiogenic action. Prog Neuropsychopharmacol 5:57?63 10.1016/0364-7722(81)90005-9

Showing 50 of 59 references

Metrics
9
Citations
59
References
Details
Published
Jul 01, 1987
Vol/Issue
92(3)
Pages
313-319
License
View
Cite This Article
M.W. Emmett-Oglesby, A. Herz (1987). Opioid modulation of the discriminative stimulus produced by pentylenetetrazol. Psychopharmacology, 92(3), 313-319. https://doi.org/10.1007/bf00210836